SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-17-008441
Filing Date
2017-02-13
Accepted
2017-02-13 11:41:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-3964_1sc13ga.htm SC 13G/A 79466
2 EX-99.1 a17-3964_1ex99d1.htm EX-99.1 6471
  Complete submission text file 0001104659-17-008441.txt   87679
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 617 772-8500
Tekla Capital Management LLC (Filed by) CIK: 0001300336 (see all company filings)

IRS No.: 010628853 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88917 | Film No.: 17597095
SIC: 8731 Services-Commercial Physical & Biological Research